A tool for targeted chemotherapy
A new test aims to identify which cancer patients benefit from being treated with ADCs.
Gene profiling test for breast cancer approved
A test that predicts which breast cancer patients benefit from chemotherapy has been approved.
NordicRWE reveals lung cancer immunotherapy study
Three leading immunotherapy drugs against lung cancer demonstrated similar overall survival in a recent comparative study from NordicRWE. The Norwegian start-up company NordicRWE has compared the effectiveness of three immunotherapies in second line treatment of advanced non-small cell lung cancer. The results indicate that the three immunotherapy drugs were equally effective in terms of overall […]
New plans for the Radium Hospital Campus
Transforming the area into an international power centre for cancer research.
Health – the next alerted crisis?
Will Norway do the necessary investments and measures for a sustainable health service?
Møt oss på Arendalsuka 2024
Velkommen til våre møter under Arendalsuka 2024! Vi ser fram til å delta på denne viktige festivalen som samler politikere, næringsliv og organisasjoner for å diskutere samfunnsaktuelle temaer. Vi skal sette kreftforskning og -innovasjon på agendaen gjennom en rekke arrangementer og samtaler med nøkkelaktører fra privat og offentlig sektor. Flere arrangementer strømmes, så følg gjerne […]
